Literature DB >> 25994578

Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis.

Li Wenlong1, Yang Leilei, Fan Wei, Chen Yi, Tian Jing, Ma Lanzhi, Liu Bing, Li Yang, Wang Shaoxia, Fu Qiuxia, Chen Zeliang, Zhao Zengming.   

Abstract

OBJECTIVES: We used optical imaging of live animals and transgenic technology to develop a pulmonary fibrosis model in mice that can non-invasively and in real-time trace the pulmonary fibrosis process.
RESULTS: Fibroblast activation protein-α (FAPα) is selectively expressed in fibrotic foci of human pulmonary fibrosis. It is not expressed in normal tissue. We confirmed that FAPα is upregulated in fibroblasts of murine pulmonary fibrosis. Moreover, TGF-β1, a central pathological mediator of fibrotic diseases, could promote FAPα expression in mouse embryonic fibroblasts. Luciferase reporter assays showed that 5.4 kb FAPα promoter response activities to TGF-β1 was stronger than of the 2.1 kb promoter. We generated a transgenic mouse line expressing firefly luciferase under the control of the 5.4 kb FAPα gene promoter (FAPα-p-luc). After experimentally inducing murine pulmonary fibrosis, there luminescence appeared in the chests and excised lungs of FAPα-p-luc mice. The intensity of luminescence became stronger with the exacerbation of pulmonary fibrosis.
CONCLUSION: Fluorescence intensity reflects the degree of pulmonary fibrosis in FAPα-p-luc mice. and this mouse model may be used to investigate molecular mechanisms and drug screening of pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25994578     DOI: 10.1007/s10529-015-1855-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  4 in total

Review 1.  The role of fibroblast activation protein in health and malignancy.

Authors:  Allison A Fitzgerald; Louis M Weiner
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  Perspective on Fibroblast Activation Protein-Specific PET/CT in Fibrotic Interstitial Lung Diseases: Imaging Fibrosis-A New Paradigm for Molecular Imaging?

Authors:  Christian Schmidkonz
Journal:  J Nucl Med       Date:  2021-10-14       Impact factor: 11.082

3.  [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity.

Authors:  Zachary T Rosenkrans; Christopher F Massey; Ksenija Bernau; Carolina A Ferreira; Justin J Jeffery; Jefree J Schulte; Melissa Moore; Frank Valla; Jeanine M Batterton; Christopher R Drake; Alan B McMillan; Nathan Sandbo; Ali Pirasteh; Reinier Hernandez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-12       Impact factor: 10.057

4.  Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy.

Authors:  Qi Fang; Shaoyu Liu; Jiangyu Cui; Ruiyue Zhao; Qian Han; Peng Hou; Youcai Li; Jie Lv; Xiaoyao Zhang; Qun Luo; Xinlu Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.